Bylvay missed the study’s primary objective of showing an improvement in native liver survival rates compared to placebo.

The drugmaker said efficacy and safety data didn’t support further development of the drug, amlitelimab, for atopic ...

The country’s Financial Services Commission said it will bring forward the introduction of the cash deposit rule to the end ...

Health is kind of the new wealth in China,” said one athletic apparel executive.

The Yemeni militants have set up a standoff in one of the world’s most vital waterways with its threats against Red Sea oil ...

The country’s incoming commander in chief has resisted the rigid, bureaucratic decision-making in the armed forces.

The president’s proposed use of an obscure Depression-era law shows courts and Congress haven’t curbed Trump’s ambition to ...

The president has grown skeptical of diplomacy and is in “revenge mode” against Tehran, according to a senior administration ...

Japan’s consumer inflation rose at a slightly faster pace in June with oil and food costs being the key factors affecting ...

The new duties, ranging from 10% to 12.5%, will replace a temporary tariff put in place after the Supreme Court derailed ...

Xi confidant leads fevered effort for domestic alternatives to win AI race. Chinese AI companies get warned that anyone who ...

Now an AI Player, Intel saw its sales of data-center chips continue to accelerate.